Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. - Wikidata - wikimedia - TriplyDB

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

http://www.wikidata.org/entity/Q35023498

about

Molecular biology of lung cancer Non-small cell lung cancer: current treatment and future advances Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC Gene aberrations for precision medicine against lung adenocarcinoma RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population Using large-scale genomics data to identify driver mutations in lung cancer: methods and challenges The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing Systemic and targeted therapies for early-stage lung cancer Review of the current targeted therapies for non-small-cell lung cancer Targeted therapies in development for non-small cell lung cancer Role of molecular studies in the diagnosis of lung adenocarcinoma Mutation of the BRAF genes in non-small cell lung cancer Molecular pathology of non-small cell lung cancer: a practical guide.Molecular pathology of lung cancer: key to personalized medicine.Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas.Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer.BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy.Liquid biopsy in early stage lung cancer Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers Characteristics of lung cancers harboring NRAS mutations Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation Lung cancer in women BRAF mutations: signaling, epidemiology, and clinical experience in multiple malignancies.High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing Beyond histology: translating tumor genotypes into clinically effective targeted therapies.Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway A meta-analysis of the association between BRAF mutation and nonsmall cell lung cancer Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts.Molecular pathways and therapeutic targets in lung cancer Molecular Testing of Lung Cancers Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice.New developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapy BRAF mutations in patients with non-small cell lung cancer: a systematic review and meta-analysis.Rapid onset lung squamous cell carcinoma with prominent peritoneal carcinomatosis and an eosinophilic leukemoid reaction, with coexistence of the BRAF V600E and oncogenic KRAS G12A mutations: A case report.Racial disparity in metabolic regulation of cancer.Non-Small Cell Lung Carcinoma Biomarker Testing: The Pathologist's Perspective Usage patterns of biomarkers in non-small-cell lung cancer patients in India: Findings from a systematic review and survey.

P2860

Q24606677-C10B0F96-7572-44AF-97B0-A9403016E401 Q26740333-0B4B83D6-BF4C-46FC-9FD2-EB82BE1E401A Q26747276-961DBC0F-1C92-4EB8-B589-283DA53721DA Q26749348-EC3BF15C-5C25-44E7-867E-E9C4E9394F8E Q26773479-FB3D7FAA-DEF0-4EE2-927F-121F795D9543 Q26786594-A8704764-E082-4304-A22F-91A19A0901BD Q26800833-A342715F-F54E-4A3E-BBCD-42FE1B82055D Q26824315-89F824C8-B077-4018-9B61-82B0B2CD737E Q26865490-9F07593D-5C59-4A73-B1E7-C4DACE1F0070 Q27015079-4C62E572-AB62-41C5-BE35-582DDE17F019 Q27022852-EF67D5E0-72A3-4AA1-BC3A-BC2777D5E397 Q27023212-859EF113-BFB4-4703-B7EA-3440E504DD0F Q27025345-C40FB96A-2DBE-4D4C-98DB-4D8E632BF03D Q27690919-BB4A1A6D-DA50-4C7C-A344-CC58939F67F1 Q27691299-60784BEC-9FF8-4B3F-A564-0519AD3CB4BC Q27851860-678E1FDC-6E5D-45E1-8AD9-A7D42A376A3C Q27852128-791ECF18-9139-4EC3-B94E-D998A0D75088 Q27853371-0703FF90-96C2-420C-9AC5-70434FC5E3FE Q28065994-758D933F-BD2A-462D-A834-964506D5D057 Q28083446-C7CDD4E1-D49A-4188-8F44-E5A3E1B728D0 Q28250795-71B59A27-F496-49C3-B38E-E91AD9F96207 Q28394324-49C1ABD7-F25B-4433-9A33-41F45082D8D4 Q28706226-42C2AEAB-8D9B-460D-98D8-24AEF6997DEA Q28730199-AF118A34-FCD7-4F47-B907-5809453AD1FF Q29248783-0DAB140C-76FC-4BC7-9DF7-8F7D327150BD Q30458424-31950166-DD40-4761-860B-F50E3F0B4E8C Q30514084-D5EC4973-8334-4E83-B323-961B6A5A4012 Q33560928-3B10E10A-3F95-4DD2-9984-3970F9FEE6CE Q33618711-EEFDFB99-74F1-4F73-9DD3-198EBFE18848 Q33621342-74541AFB-A859-44B1-B4F0-917ACBA76731 Q33682941-3C87A2ED-73FE-4ED2-897F-B607E7E2E876 Q33688872-4390CCBA-CBC0-44EA-A04F-0A557ED3B425 Q33729715-95E80541-65D1-4E3B-8C87-159387E852EA Q33757138-A1C7DD84-3D30-41DA-9F5C-76BE9DF48A23 Q33824552-89164BE2-D1F2-409C-8D50-9009D856269B Q33826001-9CCAE328-8ED6-49CF-8FC0-0CE8F6C495AC Q33843962-945B4752-714C-4DC2-8D01-03B1F38CDD4C Q33906704-7457866F-9DB6-42FD-8592-7D5A06CCDB46 Q33906921-8BD60F55-925C-40D7-ADEF-9A8BEBDBD927 Q34031517-D7AC14ED-7703-464B-96D1-7FDA75EC2D29

P2860

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

http://www.wikidata.org/entity/Q35023498

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

@ast

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

@en

type

label

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

@ast

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

@en

prefLabel

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

@ast

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

@en

P1433

Q35023498-18406E87-37E3-4845-A780-027B8B1D7B3A

P1476

Q35023498-912DB694-9F9D-4C86-BB8C-4357ACA52D6E

P2093

Q35023498-60B83C14-01AF-4A71-95B9-A4DB0858B49F

Q35023498-7073819B-8D23-4200-8237-458D5422DA6D

Q35023498-79FE0BF3-4AED-46C0-AA95-019CFE084806

Q35023498-8D6BFBDF-10B4-4F8C-BDA8-6F42CBC2B435

Q35023498-A9687845-8606-4BF1-B250-2D85F415C9D7

Q35023498-AF4AECB8-5BA2-4D3A-A7B9-93739074D19E

Q35023498-F33D8D8A-4BD9-4E72-BDA6-DA711C71DBBF

P2860

Q35023498-02E3EE9A-B6D5-4FBB-B3A5-F97B52E6D110

Q35023498-040933F4-612F-472E-A60C-FEDFC67DFE5E

Q35023498-05E50C05-94AA-464A-AD40-862BEE83DB25

Q35023498-0DD88E88-82CD-45B2-B6E0-621A09104220

Q35023498-1BFFA7EC-405D-45D5-8CC7-968B81678B5C

Q35023498-31F6C7D7-D234-49FB-A922-D6D920DE8527

Q35023498-3EF6AC49-9E45-4C11-8BAA-F2133BCD01A4

Q35023498-41F065CF-2434-4CF4-9CF2-4132C2A3330E

Q35023498-46E07CD8-B3E8-4004-A9DF-94EBE7F557FA

Q35023498-52BD230F-B4DF-4732-AFC2-5EEB93409504

P304

Q35023498-C4C5A439-049F-49FA-83E6-DD28E8F2434D

P31

Q35023498-82797D0E-959F-4AF0-B8BE-2A426F099803

P356

Q35023498-720E4BA3-4B00-4BFE-AAE6-C127817F009D

P407

Q35023498-E5CC40BE-F5CD-4C7B-AA53-9F90614E3A36

P433

Q35023498-F3B53F83-9232-4217-8497-40AE687092AD

P478

Q35023498-76216B63-99B1-40E3-9894-D7EC8A06D1E0

P50

Q35023498-D27A4337-5560-43A6-87E3-A5A03C1052FF

P577

Q35023498-99B983D6-6B24-4DF8-8B51-E9B42DDCFDB3

P698

Q35023498-C1C4AB1D-2B06-49A4-8206-13886733B475

P921

Q35023498-E9E97606-98EF-41AE-8093-89195D8D8EF7

P932

Q35023498-8C17A004-EC05-4F80-8128-B569DF9D783D

P356

JCO.2010.33.1280

P1433

Journal of Clinical Oncology

P1476

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.

@en

P2093

Camelia S Sima

http://www.w3.org/2001/XMLSchema#string

Gregory J Riely

http://www.w3.org/2001/XMLSchema#string

Maria E Arcila

http://www.w3.org/2001/XMLSchema#string

Mark G Kris

http://www.w3.org/2001/XMLSchema#string

Michael Fara

http://www.w3.org/2001/XMLSchema#string

Paul K Paik

http://www.w3.org/2001/XMLSchema#string

Vincent A Miller

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Mutations of the BRAF gene in human cancer

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

P304

2046-2051

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.33.1280

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21483012

http://www.w3.org/2001/XMLSchema#string

P921

P932

3107760

http://www.w3.org/2001/XMLSchema#string